Showing 9391-9400 of 19228 results for "".
- Preclinical Advances in Sensitizing ER-Positive Breast Cancer to Immunotherapyhttps://reachmd.com/news/preclinical-advances-in-sensitizing-er-positive-breast-cancer-to-immunotherapy/2484775/Researchers at the Hospital del Mar Research Institute report a preclinical strategy that may sensitize ER-positive tumors to immune checkpoint blockade by combining est
- Harnessing the Microbiome: Advancing IVF Success through Targeted Interventionhttps://reachmd.com/news/harnessing-the-microbiome-advancing-ivf-success-through-targeted-intervention/2484780/A prospective cohort–intervention study in 257 IVF patients demonstrates that targeted modification of the endometrial microbiome su
- Navigating the Impact of the Newly Approved Dengue Vaccine in Brazilhttps://reachmd.com/news/navigating-the-impact-of-the-newly-approved-dengue-vaccine-in-brazil/2484785/Butantan-TV dengue vaccine has been licensed in Brazil as a single-dose immunization, enabling immediate incorporation into routine programs. A one-dose regimen sh
- Post-Pandemic Adenovirus Resurgence in Pediatric Respiratory Infections: Insights from Hainan Provincehttps://reachmd.com/news/post-pandemic-adenovirus-resurgence-in-pediatric-respiratory-infections-insights-from-hainan-province/2484787/Hainan Province cohort study (children presenting to X hospitals, n≈X, late 2021–mid 2024) documents a marked post‑pandemic resurgence in pediatric adenovirus infection
- Oral Roflumilast Suppresses Psoriatic Inflammation at the Gene and Cellular Level: Studyhttps://reachmd.com/news/oral-roflumilast-suppresses-psoriatic-inflammation-at-the-gene-and-cellular-level/2484789/In a mechanistic substudy of the PSORRO trial, oral roflumilast demonstrated targeted immunomodulatory effects in patients with moderate-to-severe plaque psoriasis. Researchers for the vivo analysis sourght to characterize the dru
- Harnessing Pharmacogenetics: New Clopidogrel Guidelines and Their Clinical Implicationshttps://reachmd.com/news/harnessing-pharmacogenetics-new-clopidogrel-guidelines-and-their-clinical-implications/2484755/The UK CERSI-PGx guideline 2025 now recommends routine CYP2C19 pharmacogenetic testing before initiating clopidogrel, citing patient safety and the need to match antiplatele
- Renerva's Pioneering Step in Neuroma Pain Management: IDE Approval for First-in-Human Study of PNM-CAP Devicehttps://reachmd.com/news/renervas-pioneering-step-in-neuroma-pain-management-ide-approval-for-first-in-human-study-of-pnm-cap-device/2484758/Renerva receives FDA IDE approval to open a first-in-human study of its PNM-CAP device aimed at preventing neuroma formation in amputees and reducing opioid reliance. Renerva has received
- Minimally Invasive Surgical Innovations: The Promise of Tractionless Arthroscopyhttps://reachmd.com/news/minimally-invasive-surgical-innovations-the-promise-of-tractionless-arthroscopy/2484751/Tractionless arthroscopic irrigation and debridement rapidly reduced pain and inflammation in adults with suspected hip septic arthritis in a recent single-center series, offering a minimally invasive alternative to traction-based approaches. This finding comes from
- Advancements in HIV Diagnostics: Navigating Vaccine-Induced Challengeshttps://reachmd.com/news/advancements-in-hiv-diagnostics-navigating-vaccine-induced-challenges/2484762/Penn State researchers have developed a new HIV rapid test that distinguishes true infections from vaccine‑induced false positives. In a validation using 104 clinical samples, the devi
- Abbott Glucose Sensor Recall: Implications for Clinical Practice and Patient Safetyhttps://reachmd.com/news/abbott-glucose-sensor-recall-implications-for-clinical-practice-and-patient-safety/2484764/The FreeStyle Libre 3 sensors were recalled after internal testing showed they can report intermi